PD37-04 LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH CARDIOVASCULAR DISEASES (CVD): OBSERVATIONAL DATA FROM A REGISTRY STUDY

Hypogonadal men with cardiovascular diseases benefit from long-term treatment with testosterone undecanoate: observational data from a registry study

Endocrine Abstracts ◽

10.1530/endoabs.35.p478 ◽

2014 ◽

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Cardiovascular Diseases ◽

Observational Data ◽

Term Treatment ◽

Registry Study ◽

Improvement of Type 2 Diabetes (T2DM) and Reduction of Major Adverse Cardiovascular Events and Mortality in Hypogonadal Men Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU)—Real-Life Evidence from a Urological Registry Study

Diabetes ◽

10.2337/db18-111-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 111-LB

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Events ◽

Real Life ◽

Term Treatment ◽

Major Adverse Cardiovascular Events ◽

Registry Study ◽

178-OR: Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Lipid Profile in Men with Hypogonadism and Type 2 Diabetes in Comparison to an Untreated Control Group: Ten-Year Data from a Urological Registry Study

Diabetes ◽

10.2337/db19-178-or ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 178-OR

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Untreated Control ◽

Term Treatment ◽

Control Group ◽

Registry Study ◽

Untreated Control Group ◽

2084-P: Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study

Diabetes ◽

10.2337/db19-2084-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2084-P

Author(s):

AHMAD HAIDER ◽

KARIM S. HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Weight Loss ◽

Term Treatment ◽

Registry Study ◽

Sustained Weight Loss ◽

MP91-11 POSITIVE EFFECTS OF LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) ON RENAL FUNCTION IN HYPOGONADAL MEN: REAL-LIFE DATA FROM A PROSPECTIVE CONTROLLED REGISTRY STUDY

The Journal of Urology ◽

10.1016/j.juro.2017.02.2851 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Aksam Yassin ◽

Dany-Jan Yassin ◽

Gheorge Doros ◽

Abdulmaged Traish

Keyword(s):

Renal Function ◽

Real Life ◽

Term Treatment ◽

Registry Study ◽

Positive Effects ◽

Life Data ◽

Real Life Data ◽

Substantial weight loss in 237 hypogonadal men with obesity class I-III under long-term treatment with testosterone undecanoate (TU): Observational real-life data from a registry study

Journal of Obesity & Weight loss Therapy ◽

10.4172/2165-7904.s1.015 ◽

2015 ◽

Vol 05 (04) ◽

Author(s):

Farid Saad

Keyword(s):

Weight Loss ◽

Real Life ◽

Term Treatment ◽

Registry Study ◽

Obesity Class ◽

Life Data ◽

Real Life Data ◽

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/review2 ◽

2020 ◽

Author(s):

Kuat Oshakbayev

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Author response for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/response1 ◽

2020 ◽

Author(s):

Karim Sultan Haider ◽

Ahmad Haider ◽

Farid Saad ◽

Gheorghe Doros ◽

Markolf Hanefeld ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Author Response ◽

Registry Study ◽

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/review3 ◽

2020 ◽

Author(s):

Thomas Jones

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

1123-P: Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study

Diabetes ◽

10.2337/db19-1123-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1123-P

Author(s):

KARIM S. HAIDER ◽

AHMAD HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Events ◽

Term Treatment ◽

Major Adverse Cardiovascular Events ◽

Registry Study ◽

Long Term Treatment ◽

Reduction Of Mortality